DigOmics

Curated by Signal

AI and omics technologies for drug design and development

Overview

AI and omics technologies for drug design and development. It explore the intricacies of omics to identify precise therapeutic targets, design novel drugs, and validate mechanisms of action for drug development.

Key facts

Founded: 2009
Headquarters: Brookline, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Perform
Provider of music-enabled fitness training programs
Health TechnologySan Francisco, United States
DentaApp
Online platform to find dentists
Health TechnologyIrvine, United States
Medprex
Physician peer review management software for healthcare providers
Health TechnologyJoplin, United States

About DigOmics

What does DigOmics do?

AI and omics technologies for drug design and development.

Where is DigOmics headquartered?

DigOmics is headquartered in Brookline, United States.

When was DigOmics founded?

DigOmics was founded in 2009.

Which sector is DigOmics in?

DigOmics operates in Health Technology.

Who are DigOmics's competitors?

Companies similar to DigOmics include Perform, DentaApp, and Medprex.